Search

Author/Creator Mesa, Ruben

52. The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF). (8th November 2016)

Authors:
Mesa, Ruben; Vannucchi, Alessandro M.; Yacoub, Abdulraheem; Zachee, Pierre; Garg, Mamta; Lyons, Roger; Koschmieder, Steffen; Rinaldi, Ciro; Byrne, Jennifer; Hasan, Yasmin; Passamonti, Francesco; Verstovsek, Srdan; Hunter, Deborah; Jones, Mark M.; Zhen, Huiling; Habr, Dany; Martino, Bruno
Journal:
British journal of haematology
Issue:
Volume 176:Number 1(2017)
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

53. The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia. Issue 1 (December 2015)

Authors:
Tibes, Raoul; Al-Kali, Aref; Oliver, Gavin; Delman, Devora; Hansen, Nanna; Bhagavatula, Keerthi; Mohan, Jayaram; Rakhshan, Fariborz; Wood, Thomas; Foran, James; Mesa, Ruben; Bogenberger, James
Journal:
Journal of hematology & oncology
Issue:
Volume 8:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

55. Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet. Issue 9 (September 2021)

Authors:
Alvarez-Larrán, Alberto; Sant'Antonio, Emanuela; Harrison, Claire; Kiladjian, Jean-Jacques; Griesshammer, Martin; Mesa, Ruben; Ianotto, Jean Christophe; Palandri, Francesca; Hernández-Boluda, Juan Carlos; Birgegård, Gunnar; Nangalia, Jyoti; Koschmieder, Steffen; Rumi, Elisa; Barbui, Tiziano
Journal:
Lancet
Issue:
Volume 8:Issue 9(2021)
Page Start:
e658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗